2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
20
Stomach Neoplasms
7
Lymphoma, B-Cell, Marginal Zone
7
Lymphoma
6
Neoplasms, Plasma Cell
4
Recurrence
3
Dyspepsia
3
Peptic Ulcer
2
Gastritis
2
Skin Neoplasms
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Persistence of Infection With Helicobacter Pylori
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Infections
1
Helicobacter Infections
1
Familial primary gastric lymphoma
1
Drug-Related Side Effects and Adverse Reactions
1
Chemotherapy Effect
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Cachexia
1
B-cell Malignancies
1
Atrophy
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
9
Ciprofloxacin
8
Voriconazole
5
Vancomycin
4
Caspofungin
4
Amoxicillin-Potassium Clavulanate Combination
4
gamma-Globulins
3
Fluconazole
3
Filgrastim
3
Daptomycin
3
Antibiotic Prophylaxis
3
plerixafor
2
liposomal amphotericin B
2
Whole-Body Irradiation
2
Trimethoprim
2
Therapeutics
2
Sulfamethoxazole
2
Saline Solution
2
Ribavirin
2
Polymerase Chain Reaction
2
Piperacillin, Tazobactam Drug Combination
2
Peripheral Blood Stem Cell Transplantation
2
Pentetic Acid
2
Moxifloxacin
2
Melphalan
2
Levofloxacin
2
Lenalidomide
2
Itraconazole
2
Immunoglobulins, Intravenous
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Infections
×
Clarithromycin
×
Clear all
NCT02624440
2015-12-08
SUTRICA
Aalborg University Hospital
Phase 2
Unknown
300 enrolled